Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (401-410 of 697) with videos related to

Pageof 70
Sort By:
NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.
JAMA Oncology|February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling AnalysisKathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
Journal of the National Cancer Institute|January 10, 2014
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerJude M Mulligan, Laura A Hill, Steve Deharo, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
American Journal of Human Genetics|February 28, 2024
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domainChunling Hu, Huaizhi Huang, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
Nature Communications|April 18, 2023
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancerJodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Pageof 70

Showing results (401-410 of 697) with videos related to

Sort By:
Pageof 70
NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.
JAMA Oncology|February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling AnalysisKathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
Journal of the National Cancer Institute|January 10, 2014
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerJude M Mulligan, Laura A Hill, Steve Deharo, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
American Journal of Human Genetics|February 28, 2024
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domainChunling Hu, Huaizhi Huang, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
Nature Communications|April 18, 2023
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancerJodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Pageof 70